Alogliptin benzoate tablets are imported drugs. Alogliptin benzoate tablets is an oral hypoglycemic drug, belongs to DPP-4 inhibitor, reduces the inactivation of glucagon-like peptide-1 by inhibiting the activity of DPP-4, in order to achieve the purpose of lowering glucose, and is mainly applicable to patients with type 2 diabetes mellitus. The drug is imported and relatively expensive. However, Alogliptin benzoate tablets may have some adverse reactions such as headache and upper respiratory tract infection. It is prohibited for pregnant women, children and patients with hypersensitivity to DPP-4 inhibitors. Alogliptin benzoate tablets need to be used under the guidance of a doctor, follow the doctor’s instructions, and use medication reasonably.